Northern Trust
VOR icon

Northern Trust’s Vor Biopharma VOR Stock Holding History

Northern Trust’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Buy
328,742
+264,193
+409% +$4M ﹤0.01% 2513
2026
Q1 		$1.15M Buy
64,549
+25,603
+66% +$361K ﹤0.01% 3270
2025
Q4 		$509K Buy
+38,946
New +$725K ﹤0.01% 3647
2025
Q3 		– Sell
-3,621
Closed -$117K – 4546
2025
Q2 		$117K Sell
3,621
-3,730
-51% -$33K ﹤0.01% 4079
2025
Q1 		$105K Sell
7,351
-530
-7% -$12.7K ﹤0.01% 4102
2024
Q4 		$175K Buy
7,881
+2,213
+39% +$36.7K ﹤0.01% 4027
2024
Q3 		$79.4K Sell
5,668
-13,369
-70% -$244K ﹤0.01% 4111
2024
Q2 		$381K Sell
19,037
-881
-4% -$28.5K ﹤0.01% 3609
2024
Q1 		$944K Buy
19,918
+57
+0.3% +$2.5K ﹤0.01% 3331
2023
Q4 		$894K Buy
19,861
+2,289
+13% +$94.5K ﹤0.01% 3349
2023
Q3 		$745K Buy
17,572
+34
+0.2% +$1.84K ﹤0.01% 3388
2023
Q2 		$1.08M Buy
17,538
+14,156
+419% +$1.29M ﹤0.01% 3328
2023
Q1 		$364K Buy
3,382
+1,543
+84% +$171K ﹤0.01% 3584
2022
Q4 		$245K Buy
1,839
+683
+59% +$67.6K ﹤0.01% 3775
2022
Q3 		$92K Buy
1,156
+205
+22% +$20.2K ﹤0.01% 4140
2022
Q2 		$94K Sell
951
-6,297
-87% -$645K ﹤0.01% 4196
2022
Q1 		$875K Sell
7,248
-348
-5% -$59.2K ﹤0.01% 3482
2021
Q4 		$1.77M Sell
7,596
-57
-0.7% -$16.4K ﹤0.01% 3282
2021
Q3 		$2.4M Buy
7,653
+2,104
+38% +$625K ﹤0.01% 3189
2021
Q2 		$2.07M Sell
5,549
-549
-9% -$271K ﹤0.01% 3339
2021
Q1 		$5.26M Buy
+6,098
New +$5.16M ﹤0.01% 2715

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Northern Trust's VOR Position: Q2 2026 in Review

Northern Trust increased its Vor Biopharma (VOR) stake by 409% in Q2 2026, buying an estimated $4M and bringing the position to 328,742 shares worth $6.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Northern Trust first reported a position in VOR in Q1 2021 and has held it in 21 quarters since. 42 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Northern Trust held 328,742 shares of Vor Biopharma worth $6.05M as of Q2 2026.
  • Northern Trust bought 264,193 Vor Biopharma shares in Q2 2026, an estimated $4M.
  • Vor Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2513 holding.
  • Northern Trust first reported a position in Vor Biopharma in Q1 2021 and has held it in 21 quarters since.
  • 42 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.